Swine Respiratory Diseases Treatment Market to Reach USD 3,649.5 Million by 2032 at a 6.3% of CAGR

Explore how biotechnology and new treatments are improving swine respiratory disease management.

NEWARK, DE, UNITED STATES, February 13, 2025 /EINPresswire.com/ -- The global swine respiratory diseases treatment market is expected to grow from USD 1,978.1 million in 2022 to USD 3,649.5 million by 2032, expanding at a CAGR of 6.3% over the forecast period. The market is primarily driven by the rising prevalence of respiratory infections in swine populations, with Mycoplasma pneumonia leading the causative agent segment, holding a 35.2% market share in 2021.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 𝐭𝐨 𝐠𝐞𝐭 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: https://www.futuremarketinsights.com/report-sample#5245502d47422d34333432

Swine respiratory diseases are categorized into acute infections that spread rapidly but are short-lived, such as swine influenza, classical swine fever, and PRRS, and chronic conditions like Mycoplasma pneumonia and pleuropneumonia, which persist for extended periods. While acute outbreaks tend to be self-limiting, chronic conditions cause prolonged economic losses due to reduced growth rates and increased treatment costs.

The demand for effective vaccines, antibiotics, and biosecurity measures is expected to surge in the coming decade as farmers and veterinarians seek solutions to control infections and improve herd health. The industry will also benefit from advancements in diagnostics and precision livestock farming technologies to detect and manage diseases early.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:

The swine respiratory diseases treatment market is projected to reach USD 3.6 billion by 2032, growing at a CAGR of 6.3%.
Mycoplasma pneumonia led the causative agent segment with a 35.2% market share in 2021.
Swine influenza, classical swine fever, and PRRS are among the acute respiratory diseases, while Mycoplasma pneumonia and pleuropneumonia are chronic conditions.
Increased disease prevalence and rising treatment costs are driving the demand for vaccines, antibiotics, and biosecurity solutions.
Technological advancements in diagnostics and disease management will further support market expansion.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 - https://www.futuremarketinsights.com/reports/swine-respiratory-diseases-treatment-market

𝐒𝐰𝐢𝐧𝐞 𝐫𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐝𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 𝐟𝐚𝐥𝐥 𝐢𝐧𝐭𝐨 𝐭𝐰𝐨 𝐜𝐚𝐭𝐞𝐠𝐨𝐫𝐢𝐞𝐬 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐢𝐭𝐲 𝐚𝐧𝐝 𝐝𝐮𝐫𝐚𝐭𝐢𝐨𝐧:

Category 1 : These diseases affect a significant number of pigs and may be hazardous, but they only last a short time. The costs associated with this category are limited1. Swine influenza, classical swine fever, pneumonic pseudorabies, porcine circovirus-associated illness, and porcine reproductive and respiratory syndrome (PRRS) are examples of diseases in this category.
Category 2 : These diseases affect a large number of pigs for an extended period. Mycoplasma pneumonia and pleuropneumonia are the most common syndromes in this category, as is atrophic rhinitis.
The USA accounted for 52.9% of the North American swine respiratory diseases treatment market in 2021. The swine respiratory disease treatment market in Germany is expected to register growth at a CAGR of 5.8% over the next ten years. The swine respiratory disease treatment market in Japan is expected to register growth at a CAGR of 5.2% over the next ten years.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐰𝐢𝐧𝐞 𝐫𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭?

Several factors are driving the growth of the swine respiratory diseases treatment market:

Rising awareness of economic impact : Awareness of the economic impact of swine respiratory diseases and the need for effective treatments is driving market expansion.
Increasing pork consumption : The increase in global pork consumption, driven by population growth, changing dietary habits, and economic growth, necessitates maintaining healthy pig herds, thus driving the market.
Advancements in veterinary medicine : Advancements in veterinary medicine and innovative therapies are improving efficacy, safety, and overall outcomes, increasing the demand for swine respiratory treatment products.
Growing prevalence of swine respiratory diseases : The increasing occurrence of swine respiratory diseases, such as PRRS, swine influenza, and PCVAD, is a significant driver due to the economic losses they cause.
Increased investment in animal health : Rising investments in animal health infrastructure, diagnosis, treatment, and preventive measures reflect a growing recognition of the importance of animal health and welfare.
Government initiatives: Government investments in the pig industry, particularly aimed at supporting large pig farmers, are expected to drive demand for effective treatments.
Rising number of foodborne and zoonotic diseases : Demand for swine respiratory disease treatment options is increasing due to the rising number of foodborne and zoonotic diseases.
Emphasis on disease prevention : An increasing focus on disease prevention and biosecurity, especially in North America, is driving the use of vaccines to ensure disease-free pork production.

𝐀𝐧𝐢𝐦𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 & 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝟐𝟎+ 𝐂𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬 - https://www.futuremarketinsights.com/industry-analysis/animal-health-therapeutics

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝

Zoetis; Bayer AG; Boehringer Ingelheim GmbH; Elanco Animal Health (Sub. Eli Lilly); Virbac; Norbrook; Ceva Santé Animale; Intervet Inc., (Sub. Merck & Co. Inc.); Vetoquinol SA; Bimeda Inc.; Kyoritsu Seiyaku Corporation; HIPRA; Agrilabs, Inc.; Ashish LifeSciences Ltd.; Cipla Pharmaceuticals.; Thermo Fisher Scientific Inc.; Huvepharma

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐒𝐰𝐢𝐧𝐞 𝐑𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭

By Causative Agent:

Virus

Mycoplasma

Bacteria

Others

By Treatment:

Drugs

Antibiotics

Others

Vaccines

By Route of Administration:

Oral

Parenteral

By Distribution Channel:

Veterinary Hospitals

Veterinary Clinics

Pharmacies

Others

By Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Treatment-Resistant Hypertension Management Market Snapshot (2023 to 2033) - https://www.futuremarketinsights.com/reports/treatment-resistant-hypertension-management-market

Treatment-Resistant Depression Treatment Market Snapshot (2023 to 2033) - https://www.futuremarketinsights.com/reports/treatment-resistant-depression-treatment-market

Vietnam Aquaculture Vaccines Market Outlook 2025 to 2035 - https://www.futuremarketinsights.com/reports/vietnam-aquaculture-vaccines-market

Norway Aquaculture Vaccines Market Outlook 2025 to 2035 - https://www.futuremarketinsights.com/reports/norway-aquaculture-vaccines-market

China Aquaculture Vaccines Market Outlook 2025 to 2035 - https://www.futuremarketinsights.com/reports/china-aquaculture-vaccines-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ankush Nikam
Future Market Insights, Inc.
+ +91 90966 84197
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube
Other